BrainFit: A Study on Better Cognitive Functioning Through Braintraining on the Internet

Sponsor
Amsterdam UMC, location VUmc (Other)
Overall Status
Completed
CT.gov ID
NCT04006756
Collaborator
(none)
38
1
2
25.8
1.5

Study Details

Study Description

Brief Summary

This study evaluates the efficacy of an eight-week online cognitive training program on feasability and on objective and subjective cognitive functions in patients with late life mood disorders (LLMD). In the feasability study two training groups will be compared. The primary aim is to investigate feasability, measured by compliance attendance and satisfaction of the participants. The secondary aim is to study the possible effects of the intervention on cognitive functions. Additionally, effects on mood symptoms, social functioning, sense of mastery and quality of lide will be studied.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Online cognitive training 1
  • Behavioral: Online cognitive training 2
N/A

Detailed Description

BACKGROUND OF THE STUDY Late life mood disorders (LLMD) include patients with unipolar depression and bipolar disorder, aged 50 years and over. Despite the fact that evidence-based pharmacological and psychotherapeutic interventions have proven effective, many patients with LLMD experience relapse or partial remission.

One of the reasons for unfavorable treatment outcome is that LLMD are often accompanied with cognitive impairment (attention, processing speed, memory and executive function) during an episode and after remission.This cognitive impairment in LLMD is associated with worse social functioning , distress to patients and caregivers, decreased quality of life and an unfavorable prognosis, including nursing home admission.

Several dimensions of recovery can be distinguished and are known to influence each other. For example, addressing functional recovery by improving cognitive functioning may enhance clinical recovery (less mood symptoms) and social functioning . Therefore, addressing cognitive impairment in LLMD may improve overall functioning and recovery rates.

Strategies to improve cognitive functioning with cognitive training and/or remediation are lacking for LLMD. Cognitive training has been effective in healthy older adults and in patients with mild cognitive impairment (MCI) and dementia.

A meta-analysis of adult patients with major depressive disorder showed that computerized cognitive training is associated with improvement in depressive symptoms and everyday functioning, though effects on cognition are inconsistent, with moderate to large effects for attention, working memory and global functioning and no effects for executive functioning and verbal memory. However, a small study including both unipolar and bipolar adult patients (n=15) and a control group (n=16) observed improvements in shifting, divided attention, global executive control after an online cognitive training. In addition, improved subjective cognitive functioning, reduced depression levels and less difficulty in everyday coping were observed.

In sum, cognitive impairment is a core feature of LLMD, contributes markedly to disability but is overlooked in current evidence-based treatment programs and therefore a less positive prognosis for these patients. An effective evidence-based treatment approach addressing cognitive impairment in LLMD is warranted.

AIM To age successfully, effective coping styles and social and community involvement are important. In the general population social activities and memory training are promoted for older persons as strategies to optimize resilience and to prolong independent living. Nevertheless, for the increasing number of patients with LLMD, effective interventions to improve cognition and social functioning are not available.

With the proposed pilot study we aim to seek a feasible and effective treatment to improve cognition, social functioning and quality of life of our patients. We aim to evaluate the feasibility of the online cognitive training (BrainGymmer) in a double-blind randomized control pilot-study.

If proven to be feasible, our intention is to expand the current pilot study to a RCT to test the efficacy of the proposed online cognitive training in patients with LLMD. After efficacy has been proven, the cognitive training program can also be used in other mental health departments, and even be made available through initiatives such as GGD appstore and onlinehulpstempel.nl.

OUTCOME At baseline, after the intervention period and 3 months after training, measurements will be taken. Our primary outcome measures will feasibility and appreciation of the intervention. Evaluation of therapy compliance, drop-out, and evaluation of the patients will be done with use of questionnaires on difficulty, feasibility, joy, effort, challenge of the therapy and clearness of the intervention explanation. Furthermore, evaluation groups (also mirror groups) will be held. In these discussion groups we will evaluate the study together with patients.

Secondary outcome measures include subjective and objective cognitive functioning, mood symptoms social functioning, quality of life and sense of Mastery.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
BrainFit: The Effect of Online Cognitive Training in Patients With Late Life Mood Disorders.
Actual Study Start Date :
Sep 17, 2019
Actual Primary Completion Date :
Nov 11, 2021
Actual Study Completion Date :
Nov 11, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Online cognitive training 1

Eight-week, three times a week during 45 minutes cognitive training

Behavioral: Online cognitive training 1
Eight-week online cognitive training program, three times a week for 45 minutes. The training contains several games that are designed to train cognitive functions.

Active Comparator: Online cognitive training 2

Eight-week, three times a week during 45 minutes cognitive activities

Behavioral: Online cognitive training 2
Eight-week online active comparator program, three times a week for 45 minutes. The training contains several games.

Outcome Measures

Primary Outcome Measures

  1. Feasability of the intervention measured via therapy compliance and drop-out [Eight weeks (T1)]

    therapy compliance, drop-out

  2. Appreciation of the intervention [Eight weeks (T1)]

    Questionnaire on difficulty, feasability, joy, effort, challenge of the therapy, clearness of the intervention explanation, evaluation groups (mirror groups)

Secondary Outcome Measures

  1. Subjective cognitive functioning measured via the CFQ [Eight weeks (T1) and 3 months (T2)]

    Cognitive failures Questionnaire

  2. Genaral objective cognitive functioning via the MOCA [Eight weeks (T1) and 3 months (T2)]

    Montreal Cognitive Assessment

  3. Mood symptoms via MADRS [Eight weeks (T1) and 3 months (T2)]

    Montgomery Asberg Depression Rating Scale

  4. Quality of life via the MANSA [Eight weeks (T1) and 3 months (T2)]

    Manchester Short Assessment of quality of Life

  5. Sense of Mastery via Mastery questionnaire [Eight weeks (T1) and 3 months (T2)]

    Mastery questionnaire

  6. Physical activity via NZPAQ-SF [Eight weeks (T1) and 3 months (T2)]

    New Zealand Physical Activity Questionnaire - Short Form

  7. Believe and expectancy of the intervention via credibility/expectancy questionnaire [Week 0 (T0)]

    credibility/expectancy questionnaire

  8. Social andf occupational functioning via SOFAS [Eight weeks (T1) and 3 months (T2)]

    social and occupation functioning assessment scale

Other Outcome Measures

  1. Apathy via apathy scale [Eight weeks (T1) and 3 months (T2)]

    apathy scale

  2. Global cognitive dysfunction via the Pentagon Drawing Test [Eight weeks (T1) and 3 months (T2)]

    Pentagon Drawing Test

  3. Information processing speed and inhibition via the STROOP-test [Eight weeks (T1) and 3 months (T2)]

    STROOP-test

  4. Verbal functioning via verbal letter fluency test [Eight weeks (T1) and 3 months (T2)]

    verbal letter fluency test

  5. Cognitive functioning via SDMT [Eight weeks (T1) and 3 months (T2)]

    symbol digit modalitities test

  6. Cognitive functioning via VAT [Eight weeks (T1) and 3 months (T2)]

    Verbal Assessment Test

  7. Cognitive functioning via TMT [Eight weeks (T1) and 3 months (T2)]

    trail making test

  8. Cognitive functioning via 15-Woordentest [Eight weeks (T1) and 3 months (T2)]

    15-Woordentest

  9. Cognitive functioning via BNT short version - 30 [Eight weeks (T1) and 3 months (T2)]

    Boston naming test, short version

  10. Cogntive functioning via category fluency test [Eight weeks (T1) and 3 months (T2)]

    category fluency test

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 50 years and older

  • subjective cognitive complaints

  • early or partial remission of depressive episode with a diagnosis of unipolar recurrent depression (current episode is at least the third episode and shorter than 2 years) or bipolar disorder according to DSM 5 criteria.

  • have acces to internet on computer, tablet or lapyop

  • willing to sign informed consent

Exclusion Criteria:
  • current psychotic symptoms

  • severe suicidal ideations

  • severe personality disorder (as a main diagnosis)

  • severe alcohol or substance abuse

  • insufficient mastery of the Dutch language.

  • on 2 or more cognitive domains below 1 SD of the norm

  • moca < 22

Contacts and Locations

Locations

Site City State Country Postal Code
1 GGZ inGeest Amsterdam Noord-Holland Netherlands 1081 JC

Sponsors and Collaborators

  • Amsterdam UMC, location VUmc

Investigators

  • Principal Investigator: Annemiek Dols, MD, PhD, Amsterdam UMC, location VUmc
  • Principal Investigator: Mardien Oudega, MD, PhD, Amsterdam UMC, location VUmc

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Annemiek Dols, MD, PhD, Psychiatrist, Prinicipal Investigator, Amsterdam UMC, location VUmc
ClinicalTrials.gov Identifier:
NCT04006756
Other Study ID Numbers:
  • NL58750.029.16
First Posted:
Jul 5, 2019
Last Update Posted:
Dec 1, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2021